The COVID-19 pandemic has demonstrated how vulnerable human beings and societies are to a new infectious...
OPINION
Experts Point of View
New entrants and variants will be main drivers of the COVID-19 vaccine market as supply gradually begins
to...
The Commission study on Novel Genomic Techniques (NGTs) underlines that plants resulting from NGTs have the...
IP U.S. reverses stance, backs giving poorer countries access to COVID vaccine patents:
President Joe Biden...
European biotechs have been longly undervalued. In the wake of the COVID-19 pandemic, some of them took off....
It has been a roller coaster ride for biotechnology since Covid-19 became the virus du jour in early 2020. In...
Share
